Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedLocation entries for Chile are updated to use shorter regional labels (e.g., “Araucania” and “Valparaiso”) alongside the same city and site details. The page footer revision version is also incremented from v3.5.0 to v3.5.3.SummaryDifference0.4%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedRevision label updated to v3.5.0. The previous label v3.4.3 was removed.SummaryDifference0.0%

- Check61 days agoChange Detected- Added Revision: v3.4.3 - Deleted Revision: v3.4.2SummaryDifference0.0%

- Check82 days agoChange DetectedThe page now displays 'Revision: v3.4.2' and no longer shows 'Revision: v3.4.1'.SummaryDifference0.0%

- Check90 days agoChange DetectedPlain Language Summary has been added to the Study Details page, and the record shows a new revision (v3.4.1). The previous revision (v3.4.0) was removed and new date entries for 2026-02-05, 2026-01-15, and 2025-12 were added.SummaryDifference0.1%

- Check104 days agoChange DetectedAdded UI controls to show/hide the glossary and updated metadata sections to include Last Update Submitted that Met QC Criteria and Last Update Posted, plus No FEAR Act Data with Revision: v3.4.0. Removed the older labels and the previous revision v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.